Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product includes PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.
Research context
Analytica Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Analytica Limited is currently in a long term downtrend where the price is trading 16.8% below its 200 day moving average.
From a valuation standpoint, the stock is 260.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 928.9.
Analytica Limited's total revenue rose by 7.2% to $781K since the same quarter in the previous year.
Its net income has dropped by 10.7% to $-450K since the same quarter in the previous year.
Finally, its free cash flow grew by 44.5% to $-190K since the same quarter in the previous year.
Based on the above factors, Analytica Limited gets an overall score of 2/5.